Post-Irradiation Sinus Mucosa Disease in Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Proton Therapy.
07/01/2022
/
Publications
/
IMPT
VMAT
This study by the researchers from Taiwan compared the incidence and severity of chronic rhinosinusitis (CRS) in NPC patients who were treated with IMPT (n=53)...
Pencil-beam scanning proton therapy for the treatment of glomus jugulare tumours.
13/08/2022
/
Publications
/
IMPT
Pencil Beam Scanning - PBS
This study by the group from Prague, Czech Republic, reported early outcomes of 12 patients with glomus jugulare tumours (GJT) treated with IMPT to a median...
High-dose Intensity-modulated proton therapy versus Standard-dose Intensity-modulated RadIation therapy for esophageal squamous cell carcinoma (HI-SIRI): study protocol for a randomized controlled clinical trial.
15/11/2022
/
Publications
/
IMPT
IMRT
This is a study protocol details a randomized trial taking place in Thailand with multiple centers comparing IMPT and IMRT for stage II–IVA squamous thoracic...
Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer.
15/11/2022
/
Publications
/
IMPT
IMRT
163 consecutively treated patients with biopsy-proven, stage III NSCLC who received IMPT (n = 35, 21%) or IMRT (n = 128, 79%) were analyzed in this study...
Clinical experience from the first compact IMPT Proton Therapy Center: the advantages of treating in an open gantry environment
26/01/2018
/
Event
/
IMPT
The Willis-Knighton Health System, headquartered in Shreveport, Louisiana, is a not-for-profit community healthcare corporation with four general acute care...
Model-based for nasopharyngeal carcinoma
24/09/2020
/
Webinar
/
Model-based approach
VMAT
ARC therapy
IMRT
IMPT
Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy.
28/03/2024
/
Publications
/
IMPT
IMRT
Toxicity
This study reported the incidence of lymphopenia in 271 stage III NSCLC patients treated with IMPT (n=71) vs IMRT (n=200) and concurrent chemotherapy. The...
Comparing the oncologic outcomes of proton therapy and intensity-modulated radiation therapy for head and neck squamous cell carcinoma.
08/04/2024
/
Publications
/
IMRT
IMPT
To compare the oncologic outcomes between proton therapy and intensity-modulated radiation therapy (IMRT) for head and neck squamous cell carcinoma (HNSCC)...
Longitudinal Assessment of Quality of Life in Nasopharyngeal Cancer Patients Treated with Intensity-Modulated Proton Therapy and Volumetric Modulated Arc Therapy at Different Time Points.
06/05/2024
/
Publications
/
IMPT
Quality of life
VMAT
This is a longitudinal assessment of QoL on 287 NPC patients treated with IMPT (n=41) and VMAT (n=246). Both groups exhibited improved scores of global QoL...
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.
14/06/2021
/
Publications
/
Toxicity
Survival
IMPT
Seventy-seven patients with nonmetastatic NPC received IMPT (n=28) or IMRT(n=49). With a median follow-up time of 30.3 months, IMPT was associated with lower...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.